Fermeate
Fermeate provides an optogenetic control platform that retrofits onto existing industrial bioreactors, using light-responsive protein circuits to enable real-time metabolic control of fermentation microorganisms. The company serves industrial fermentation operators across amino acids, proteins, food ingredients, specialty chemicals, flavors, and ag biologicals.
- Company typePrivate
- Founded2024
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Fermeate does
Fermeate is a San Francisco-based industrial biotechnology company that has developed an optogenetic control platform for industrial precision fermentation. The company's technology embeds light-responsive protein circuits into production microorganisms' genetics, enabling operators to actively steer microbial metabolism — shifting from growth to production phase, switching carbon sources, or enforcing drift-resistant configurations — during active fermentation runs. A compact external hardware module connects to existing bioreactors through standard ports, draws a small broth volume, delivers a precisely timed light pulse, and returns the culture to the tank, eliminating the need for new tanks, process downtime, or tank requalification. The platform has demonstrated feasibility across bacteria (E. coli, C. glutamicum, Bacillus subtilis), yeast (S. cerevisiae, Pichia pastoris/K. phaffii), and filamentous fungi (Aspergillus).
Founded in 2024 by Princeton PhD alumni Kevin Xu (CEO) and Saurabh Malani (CTO), with technology licensed or spun out from the Avalos Lab at Princeton University, Fermeate targets industrial fermentation operators across amino acid production, protein production, food and specialty ingredients, specialty chemicals, flavors and fragrances, industrial enzymes, biofuels, and agricultural biologicals. Revenue is currently generated through paid pilot projects and engineering partnerships; four global food and ingredient companies are actively engaged, with additional revenue potential from licensing the optogenetic platform and selling hardware modules to retrofit existing bioreactors.
The company monetizes via a hybrid early-stage revenue model combining paid pilot engineering services with a future licensing/hardware module sales motion at less than 5% of new tank installation cost and an under-11-month payback period. Go-to-market is direct enterprise field sales to fermentation operators, complemented by event-driven accelerator participation (BEAM Circular, BioCatalyst 2026) and thought-leadership content marketing including an interactive ROI Calculator. The company closed a $2 million seed round in April 2026 led by Newfund Capital with participation from SOSV, Ajinomoto Group Ventures, and six other investors, while remaining a sub-10-person team headquartered at 2565 3rd St, San Francisco, CA.
Fermeate firmographics
Firmographics- Name
- Fermeate
- Legal name
- Fermeate, Inc.
- Website
- https://fermeate.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Fermeate provides an optogenetic control platform that retrofits onto existing industrial bioreactors, using light-responsive protein circuits to enable real-time metabolic control of fermentation microorganisms. The company serves industrial fermentation operators across amino acids, proteins, food ingredients, specialty chemicals, flavors, and ag biologicals.
- Ownership category
- akta.pro rank
Fermeate industry classification
Industry- Product category
- Industrial Bioprocess Technology
- akta.pro primary industry
- Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation) (AFAJAHAH)
- akta.pro secondary industries
- Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation) (AFAKAGAH), Fermentation Substrates & Sugars (Molasses, Glucose Syrups, Lactose, Malt Extract) (AFAJAJAI)
Keywords
Where Fermeate is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Fermeate business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Precision Fermentation Technology Partnerships: Revenue generated through paid pilot projects and engineering partnerships with fermentation companies. Partnerships include process reviews, genetic work scoping, and implementation of optogenetic solutions tailored to specific strain and yield targets.
- Technology Licensing and Platform Access: Potential revenue from licensing the optogenetic control platform and hardware modules to industrial fermentation operators, retrofitted onto existing bioreactors.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Fermeate product offering
Product offeringCore offering
Fermeate provides an optogenetic control platform for industrial fermentation that embeds engineered light-responsive protein circuits into production microorganisms and pairs them with a compact hardware module connecting to existing bioreactors. The system enables real-time metabolic control during active fermentation runs, allowing producers to shift microbes between growth and production phases, switch carbon sources, and stabilize strains against genetic drift without modifying tanks or interrupting production. Current commercial delivery is via paid pilot projects, engineering partnerships, and tailored process reviews with global fermentation operators.
Product overview
Fermeate offers a unified optogenetic control platform for industrial fermentation, consisting of the core Optogenetic Control Platform (software/technology layer) and the accompanying Hardware Module (physical add-on). The platform enables real-time control of microbial gene expression during fermentation runs using light-sensitive genetic switches. The ROI Calculator is a complementary web tool for prospect engagement. The system works across bacteria, yeast, and filamentous fungi and is designed to retrofit existing bioreactors without requiring new tanks, process interruption, or requalification.
Differentiator
Problem solved
Functional benefit
Products and services
- Fermeate Optogenetic Control Platform The core optogenetics platform that uses light-responsive protein circuits integrated into production organisms' genetics, enabling real-time metabolic control during fermentation runs. The platform allows producers to shift metabolism, switch carbon sources, or lock in production behavior at precisely the right moment without modifying existing tanks, targeting industrial fermentation operators across bacteria, yeast, and filamentous fungi.
- Fermeate Hardware Module A compact external unit that connects to existing bioreactors through standard access ports. During a run it draws a small volume of culture broth, exposes it to a precisely timed pulse of light, and returns it to the tank. For a 100,000-liter bioreactor the module is approximately the size of a 125-gallon water heater (80" height x 30" width) and connects through ports the tanks already have, requiring no vessel modification or process interruption.
Quantifiable outcome
- 60-300% fermentation output improvement
- +4 more outcomes
Companies that use Fermeate
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Fermeate technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
Fermeate partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and foundational.
- Global Food and Ingredient CompaniescoreFour global food and ingredient companies engaged in active partnerships with Fermeate for implementation of optogenetic control platform. Currently generating revenue from several paid projects.
- BEAM Circular Accelerator / gener8torcore12-week hybrid accelerator program based in California's North San Joaquin Valley providing $100,000 in grants and incentive funding, mentorship, investor access, and connections to CA Bioeconomy Innovation Campus. Sponsored by Almond Board of California and CA Jobs First.
- National University of Singapore (NUS) / Enterprise SingaporecoreWon Bezos Centre for Sustainable Protein Challenge providing up to S$175,000 in funding and in-kind support including laboratory space, office space, mentorship, and pilot-trial opportunities in Singapore. Access to Asia-Pacific innovation ecosystem.
- Avalos Lab (Princeton University)foundationalResearch foundation from Princeton University where founders Kevin Xu and Saurabh Malani developed the core optogenetics technology. Over a decade of R&D underpinning the platform.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
Fermeate competitors and assessment
Company assessmentDirect peers
- Culture Biosciences: Provides fermentation process development and bioreactor services to industrial biotech customers, with a focus on data-rich process optimization. Directly comparable as a technology-enabled service provider targeting yield and process improvements in industrial fermentation.
- Cauldron: Precision fermentation scale-up infrastructure provider for industrial biomanufacturing. Comparable as a fermentation scale-up enabler serving the same customer base of food ingredient and alternative protein producers.
- Pow.bio: AI-driven precision fermentation platform focused on continuous biomanufacturing and strain optimization. Directly comparable as a technology-enabled fermentation services provider improving yields and economics for industrial customers.
Broad incumbents
- Novozymes: Global leader in industrial enzymes and microbial solutions. Comparable as a major industrial fermentation incumbent that could either partner with Fermeate or compete through in-house process optimization capabilities.
- Ginkgo Bioworks: Large-scale organism engineering and biomanufacturing platform serving industrial customers across food, agriculture, and specialty chemicals. Comparable as a B2B provider of engineered microbial solutions to industrial fermentation customers, though operating at vastly greater scale and scope.
- LanzaTech: Industrial biotechnology company using gas fermentation to produce fuels and chemicals. Comparable as a large-scale industrial fermentation operator that could be both a customer and adjacent competitor in process optimization.
Emerging players
- The EVERY Company: Precision fermentation producer of animal-free proteins using engineered yeast. Comparable as a fermentation-based ingredient company that could benefit from Fermeate's dynamic metabolic control technology.
- Perfect Day: Precision fermentation company producing animal-free dairy proteins. Comparable as a precision fermentation end-user that would be a potential customer for Fermeate's optogenetic control platform to improve strain yields.
- Biosyntia: Precision fermentation company developing sustainable vitamins and fine ingredients using engineered microbes. Comparable as a fermentation ingredient producer with strain engineering needs that align with Fermeate's value proposition.
Regional players
- Cibus: Agricultural biotechnology company developing microbial solutions for crop improvement. Comparable in the agricultural biologicals use case Fermeate targets, though focused on plant traits rather than fermentation control.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Fermeate social profiles
Digital presenceFermeate financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fermeate leadership team
Management profileNumber of profiles
Profiles6 records
Fermeate funding detail
Funding detailFunding overview
Funding rounds4 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fermeate M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fermeate
What does Fermeate do?
Fermeate provides an optogenetic control platform for industrial fermentation that embeds engineered light-responsive protein circuits into production microorganisms and pairs them with a compact hardware module connecting to existing bioreactors. The system enables real-time metabolic control during active fermentation runs, allowing producers to shift microbes between growth and production phases, switch carbon sources, and stabilize strains against genetic drift without modifying tanks or interrupting production. Current commercial delivery is via paid pilot projects, engineering partnerships, and tailored process reviews with global fermentation operators.
Is Fermeate a public or private company?
Fermeate is a private company. It is classified as venture growth investor backed and is currently operating.
When was Fermeate founded?
Fermeate was founded in 2024. It employs 1 to 10 people.
Where is Fermeate based?
Fermeate is headquartered in San Francisco, United States, in the North America region.
How does Fermeate make money?
Two revenue lines are on record. Precision Fermentation Technology Partnerships are the primary driver. The others are technology Licensing and Platform Access.
Who are Fermeate's main competitors?
Direct peers on record are Culture Biosciences, Cauldron and Pow.bio. Broad incumbents are Novozymes, Ginkgo Bioworks and LanzaTech. Emerging players are The EVERY Company, Perfect Day and Biosyntia. Cibus is listed as a regional player.
Does Fermeate have an API?
No public API is recorded for Fermeate.
What industry is Fermeate in?
Fermeate's product category is Industrial Bioprocess Technology. Its primary akta.pro industry code is AFAJAHAH, Fermentation-Derived Proteins (Precision Fermentation, Biomass Fermentation), with a secondary code of AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation).